Bayley Matthew D 4/A
4/A · Aevi Genomic Medicine, Inc. · Filed Jul 18, 2018
Insider Transaction Report
Form 4/AAmended
Bayley Matthew D
Director
Transactions
- Award
Stock Option (Right to Purchase)
2018-06-14+50,000→ 50,000 totalExercise: $1.55Exp: 2028-04-17→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The option award was granted on April 17, 2018 and was subject to forfeiture if stockholder approval of a proposed amendment to the Issuer's stock incentive plan to increase the number of shares reserved for issuance under the plan was not obtained. The Issuer's stockholders approved the amendment to the Issuer's stock incentive plan at the Issuer's annual meeting of stockholders on June 14, 2018.
- [F2]This amendment is being filed to amend the vesting schedule of the option award. The entire option award vests and becomes exercisable on April 17, 2019, subject to the reporting person's continued service with the Issuer. The reporting person is the Chief Strategy Officer at The Children's Hospital of Philadelphia and he holds this option award for the benefit of The Children's Hospital of Philadelphia Foundation.